More about

Pruritus

News
July 03, 2024
2 min read
Save

Maralixibat improves pruritis, reduces total serum bile acids in all PFIC subtypes

Maralixibat improves pruritis, reduces total serum bile acids in all PFIC subtypes

Maralixibat improved cholestatic pruritis and reduced serum bile acids in pediatric patients with progressive familial intrahepatic cholestasis, regardless of disease genotype, according to data from the MARCH-PFIC trial.

News
June 11, 2024
2 min read
Save

Abrocitinib may be ‘promising treatment’ for prurigo nodularis, chronic pruritus

Abrocitinib may be ‘promising treatment’ for prurigo nodularis, chronic pruritus

Abrocitinib may be an effective and well-tolerated treatment for adults with prurigo nodularis and chronic pruritus of unknown origins, according to a study.

News
June 06, 2024
3 min read
Save

Elafibranor has ‘significant, sustained treatment benefit’ in PBC through 78 weeks

Elafibranor has ‘significant, sustained treatment benefit’ in PBC through 78 weeks

Elafibranor sustained biochemical response through week 78 in patients with primary biliary cholangitis and has a “potential beneficial effect” on itch-related quality of life, according to late-breaking data presented at EASL Congress.

News
May 14, 2024
1 min read
Save

OTC healing ointment improves dry skin, surgical wounds

OTC healing ointment improves dry skin, surgical wounds

Over-the-counter healing ointment was safe and effective for treating dry, itchy skin and surgical wounds from dermatologic procedures, according to a study.

News
May 08, 2024
1 min read
Save

Nemolizumab filings for prurigo nodularis, atopic dermatitis accepted in four countries

Nemolizumab filings for prurigo nodularis, atopic dermatitis accepted in four countries

Galderma has received filing acceptances for nemolizumab for the treatment of prurigo nodularis and atopic dermatitis in Australia, Singapore, Switzerland and the United Kingdom, the company announced in a press release.

News
April 24, 2024
1 min read
Save

Incyte adds to pipeline with acquisition of Escient Pharmaceuticals

Incyte adds to pipeline with acquisition of Escient Pharmaceuticals

Incyte and Escient Pharmaceuticals have entered a definitive agreement under which Incyte will acquire Escient for $750 million, the companies announced in a press release.

News
February 22, 2024
2 min read
Save

US expert consensus guidelines target advancing care in neuropathic pruritus

US expert consensus guidelines target advancing care in neuropathic pruritus

Researchers have published an expert consensus on uniform nomenclature and diagnosis for neuropathic pruritus in the United States.

News
February 16, 2024
2 min read
Save

Children, adolescents with difficult-to-control AD benefit from multidisciplinary approach

Children, adolescents with difficult-to-control AD benefit from multidisciplinary approach

Children and adolescents with difficult-to-control atopic dermatitis can benefit from a multidisciplinary approach that combines the perspectives of dermatologists, allergists and family members, according to a study.

News
February 13, 2024
2 min read
Save

Severity of CKD-associated pruritus linked to all-cause mortality, other comorbidities

Severity of CKD-associated pruritus linked to all-cause mortality, other comorbidities

The severity of chronic kidney disease-associated pruritus may be linked with higher risks of all-cause mortality, hospitalizations, cardiovascular events and infections, data show.

News
February 10, 2024
1 min read
Save

Regular checks, gentle products recommended for aging skin

Regular checks, gentle products recommended for aging skin

MIAMI BEACH, Fla. — Xerosis can be a significant issue for patients as they age and dermatology practioners should both be aware and remain vigilant with whole body checks in older patients according to a poster presentation here.

View more